Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases, Hereditary

Explore clinical trials studying Eye Diseases, Hereditary. Study availability and eligibility vary by location and protocol.

836 public trials 191 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases, Hereditary trial results

Completed

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05795699

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases, Corneal Dystrophies, Hereditary, +5 more
Locations
  • Keck Hospital of USC Los Angeles, California, United States
  • Macy Eye Center Los Angeles, California, United States
  • Jules Stein Eye Institute Los Angeles, California, United States
  • Byers Eye Institute at Stanford Palo Alto, California, United States
View all 50 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

NCT06270836

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +14 more
Locations
  • Retina Associates SW Tucson, Arizona, United States
  • Retina Consultants of Orange County Fullerton, California, United States
  • Global Research Management, Inc. - Lugene Eye Institute Glendale, California, United States
  • Retinal Consultants Medical Group, Inc. Modesto, California, United States
View all 39 locations
View Trial Details
Completed

Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome

NCT03717909

Conditions
Abnormalities, Multiple, Blindness, Congenital Abnormalities, +35 more
Locations
  • CHU de Montpellier, Hopital Gui de Chauliac Montpellier, France
  • Hôpital Européen Georges-Pompidou Paris, France
  • Medical University of Lodz Lodz, Poland
  • Unidad de Gestión Clínica Almería Periferia. Distrito Sanitario Almería Almería, Spain
View Trial Details
Completed

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

NCT05282953

Conditions
Choroid Diseases, Choroideremia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Save Sight Institute Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Harley Eye Clinic North Adelaide, South Australia, Australia
View Trial Details
Completed

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

NCT06384547

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • United Medical Research Institute Inglewood, California, United States
  • Advancing Research International, LLC Los Angeles, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
  • Cockerham Eye Consultants, PC San Diego, California, United States
View all 50 locations
View Trial Details
Completed

An Open-label Study (OLE) for Non-responders of VRDN-001-101 (NCT05176639) and VRDN-001-301 (NCT06021054)

NCT06179875

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Eye Institute Los Angeles, California, United States
  • Advancing Research International, LLC Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 45 locations
View Trial Details

Related conditions